RTOG 0131: Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliornas and mixed anaplastic oligodendrogliomas: Relationship between lp/19q status and progression-free survival. Conference

Vogelbaum, MA, Berkey, B, Peereboom, D et al. (2006). RTOG 0131: Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliornas and mixed anaplastic oligodendrogliomas: Relationship between lp/19q status and progression-free survival. . JOURNAL OF CLINICAL ONCOLOGY, 24(18), 62S-62S.

cited authors

  • Vogelbaum, MA; Berkey, B; Peereboom, D; Giannini, C; Jenkins, R; Suh, J; Brown, P; Blumenthal, D; Biggs, C; Mehta, M

authors

date/time interval

  • June 2, 2006 -

publication date

  • June 20, 2006

webpage

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Location

  • Atlanta, GA

Conference

  • 42nd Annual Meeting of the American-Society-of-Clinical-Oncology

publisher

  • AMER SOC CLINICAL ONCOLOGY

start page

  • 62S

end page

  • 62S

volume

  • 24

issue

  • 18